Nov 15, 2009 - Price Matching Initiative
SynDaver™ Labs announced today a price-matching initiative on competitive vascular models. The company will now match or beat quotes or published prices for both stock and custom products made by Elastrat, Dynatek, or any other competitor. Quotes must be less than 60 days old.
June 27, 2009 - MD&M West Show 2010
Components from our SynDaver™ synthetic human will be shown at the upcoming MD&M West show, held February 9, 10, and 11, 2010 at the Anaheim Convention Center in Anaheim, California. This will be the first public viewing for many SynDaver™ technologies, and our founder,
Dr. Christopher Sakezles, will be on hand to answer questions regarding our products.
May 5, 2009 - SynDaver™ Synthetic Cadaver Alpha
Our SynDaver™ synthetic human cadaver was delivered to alpha testing today. This 'head-to-toe' simulator includes several hundred replaceable muscles, tendons, arteries, veins, and organs, as well as skin, fat, and fascia pads. This product is designed to be a universal surgical simulator, clinial task trainer, and medical device test bed. Click
[Here] to become a beta test site.
Mar 24, 2009 - Our 3rd U.S. Patent
Our third U.S. patent (No 7,507,092) issued today. The patent covers synthetic human body parts with living cells. This technology will expand the use of SynDaver™ Labs' technology beyond medical device testing to pharmaceuticals, cosmetics, and consumer products
[More].
Mar 5, 2009 - Public SynDaver™ Lab
Our new synthetic cadaver lab opened in Tampa today. This facility will allow those unfamiliar with our synthetic human tissues to work with them directly. This location stocks replacement parts for most of our products and is also equipped for medical device tests and clinical training.
[More].
Sep 23, 2008 - Our 2nd U.S. Patent
Our second U.S. patent (No 7,427,199) issued today. The patent covers the design of synthetic human body parts and the formulation of synthetic human tissues for medical device testing, surgical simulation, and clinical task training.
[More].
